Venus Concept Inc.
VERODelisted Jan 30, 2026- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001409269
Venus Concept Inc. was delisted on Jan 30, 2026; its insiders filed their last Form 4 on Mar 30, 2026; 9 institutions reported holding it in 13F filings for Q4 2025, worth $189.5K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 9
- Q4 2025, −1 vs. previous quarter
- 13F value
- $189.5K
- Reported value at the end of Q4 2025
- Superinvestors holding
- 0
- At the end of Q4 2025
Superinvestors holding VERO, Q4 2025
No superinvestor reported holding VERO at the end of Q4 2025.
Latest insider trades
Open-market purchases and sales by Venus Concept Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 (view filing)9:16 PM ET | Mar 26 | 4 days | Madryn Health Partners, LP and 3 others10% Owner | PPurchase | +37.5M | $0.04 | +$1.50M | +368,517.4%37.5M after | 2 lots |
| Mar 30, 2026 (view filing)9:16 PM ET | Mar 26 | 4 days | Madryn Health Partners, LP and 3 others10% Owner | PPurchase | +682.9K | – | – | –1.83M after | Derivative4 lots |
| Mar 27, 2026 (view filing)4:05 PM ET | Mar 26 | 1 day | EW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 3, 5, 7 and 8 | SSale | −668.7K | – | – | – | Derivative3 lots |
| Oct 2, 2025 (view filing)7:23 PM ET | Sep 30 | 2 days | Madryn Asset Management, LP and 2 others10% Owner | PPurchase | +4.96M | – | – | –2.03M after | Derivative |
| Jul 2, 2025 (view filing)7:27 PM ET | Jun 30 | 2 days | Madryn Health Partners, LP and 3 others10% Owner | PPurchase | +3.00M | – | – | –1.49M after | Derivative2 lots |
| Apr 2, 2025 (view filing)5:47 PM ET | Mar 31 | 2 days | Madryn Health Partners, LP and 3 others10% Owner | PPurchase | +3.51M | – | – | –1.16M after | Derivative2 lots |
| Dec 4, 2024 (view filing)5:43 PM ET | Dec 3 | 1 day | Natale AnthonyDirector | SSale | −42.8K | $0.3085 | −$13.2K | −100.0%0 after | |
| Oct 7, 2024 (view filing) | Oct 3 | 4 days | Masters Michael Willingham10% Owner | SSaleCommon Stock, $0.0001 par value per share | −162.9K | $0.53 | −$86.3K | −43.7%209.8K after | 5 lots |
| Oct 2, 2024 (view filing) | Sep 30-Oct 2 | 2 days | Masters Michael Willingham10% Owner | SSaleCommon Stock, $0.0001 par value per share | −306.1K | $0.5877 | −$179.9K | −53.1%270.1K after | 15 lots |
| Sep 30, 2024 (view filing)8:20 PM ET | Sep 26 | 4 days | Madryn Health Partners, LP and 3 others10% Owner | PPurchase | +20.4M | – | – | –780.6K after | Derivative |
Top 10 13F holders, Q4 2025
The largest institutional positions in Venus Concept Inc. at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 99,021 | $146.6K | 0.05% | 00.0% | Unchanged |
| Madryn Asset Management, LP | 10,186 | $15.1K | 0.04% | +10,186 | New |
| Virtu Financial LLC | 10,442 | $15.0K | 0.00% | +10,442 | New |
| UBS Group AG | 5,520 | $8.17K | 0.00% | −2,268−29.1% | Reduced |
| Tower Research Capital LLC (TRC) | 3,070 | $4.54K | 0.00% | +1,127+58.0% | Added |
| SBI Securities Co., Ltd. | 86 | $127 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 14 | $21 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 7 | $10 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $1 | 0.00% | −715−99.9% | Reduced |
Holders of 5% or more of VERO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Venus Concept Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Madryn Asset Management, LP | 13D/A | 100.00%57.0M shares | +9.00 ppfrom 91.00% | Oct 12, 202314 filings | Mar 30, 2026 | SEC |
| HealthQuest Partners II, L.P. | 13D/A | 9.90%7.55M shares | – | Feb 11, 20223 filings | Feb 14, 2025 | SEC |